Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.94 CHF | -0.52% | +2.59% | +11.12% |
Apr. 29 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
Apr. 29 | Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump | MT |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 40.26 and 31.01 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 3.91 times its current sales, is high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.12% | 39.88B | B | ||
-2.77% | 18.57B | B- | ||
-14.88% | 2.42B | D+ | ||
-11.77% | 1.5B | C+ | ||
+24.21% | 1.19B | - | ||
-34.38% | 778M | - | ||
-35.31% | 752M | B- | ||
-8.66% | 671M | - | ||
+26.26% | 511M | - | - | |
+23.80% | 486M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ALC Stock
- Ratings Alcon Inc.